Drug Trial Radar · NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,500
Planned (sponsor's estimate)
Start
Jun 29, 2026
Primary completion
Jul 31, 2028
Study completion Jul 30, 2029
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is a global, randomized, double-blind, parallel-group, multicenter, Phase III study to assess the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adults living with obesity or overweight with at least one weight-related comorbidity, and without T2DM (Study 1) or with T2DM (Study 2).
Conditions
- Weight Management
Interventions
ElecoglipronDrug
Elecoglipron film-coated tablet once daily
PlaceboDrug
Placebo matching elecoglipron film-coated tablet once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent body weight lossTime frame: 72 weeks
Locations
325 sites in 19 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Recruiting
Research Site
Dothan, Alabama · Recruiting
Research Site
Chandler, Arizona · Recruiting
Research Site
Sun City, Arizona · Not yet recruiting
Research Site
Little Rock, Arkansas · Recruiting
Research Site
Lynwood, California · Recruiting
Research Site
Rolling Hills Estates, California · Recruiting
Research Site
Sacramento, California · Recruiting
Research Site
Arvada, Colorado · Recruiting
Research Site
New Haven, Connecticut · Not yet recruiting
Research Site
Plantation, Florida · Not yet recruiting
Research Site
Tampa, Florida · Recruiting
Research Site
Woodstock, Georgia · Recruiting
Research Site
Ammon, Idaho · Recruiting
Research Site
Melrose Park, Illinois · Recruiting
Research Site
Indianapolis, Indiana · Recruiting
Research Site
Wichita, Kansas · Recruiting
Research Site
Louisville, Kentucky · Recruiting
Research Site
Alexandria, Louisiana · Recruiting
Research Site
Baltimore, Maryland · Not yet recruiting
Research Site
Potomac, Maryland · Recruiting
Research Site
White Marsh, Maryland · Recruiting
Research Site
Ypsilanti, Michigan · Withdrawn
Research Site
Ridgeland, Mississippi · Recruiting
Research Site
Kansas City, Missouri · Recruiting
Research Site
St Louis, Missouri · Recruiting
Research Site
Reno, Nevada · Not yet recruiting
Research Site
Albuquerque, New Mexico · Recruiting
Research Site
Albany, New York · Not yet recruiting
Research Site
Laurelton, New York · Recruiting
Research Site
Long Island City, New York · Recruiting
Research Site
Greensboro, North Carolina · Recruiting
Research Site
Raleigh, North Carolina · Recruiting
Research Site
Rocky Mount, North Carolina · Recruiting
Research Site
Statesville, North Carolina · Recruiting
Research Site
Columbus, Ohio · Recruiting
Research Site
Dayton, Ohio · Recruiting
Research Site
Oklahoma City, Oklahoma · Recruiting
Research Site
Tulsa, Oklahoma · Recruiting
Research Site
Portland, Oregon · Not yet recruiting
Showing 40 of 325 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.